SENSEX NIFTY

Divis Laboratories

Apr 29, 2016 at 08:05 | Source: CNBC-TV18
Manas Jaiswal of manasjaiswal.com is of the view that one can buy ILandFS Investment Managers with a target of Rs 20 and Piramal Enterprises with a target of Rs 1210.
Apr 28, 2016 at 08:25 | Source: CNBC-TV18
Manas Jaiswal of manasjaiswal.com recommends buying Adani Port with a target of Rs 250 and Aban Offshore with a target of Rs 234.
Apr 22, 2016 at 09:21 | Source: CNBC-TV18
Ashwani Gujral of ashwanigujral.com is of the view that one can buy Divis Lab and PVR.
Apr 21, 2016 at 15:23 | Source: CNBC-TV18
Ashwani Gujral of ashwanigujral.com is of the view that one can buy Firstsource Solutions and advises selling TCS and Ambuja Cements.
Apr 21, 2016 at 13:34 | Source: CNBC-TV18
Sudarshan Sukhani of s2analytics.com is of the view that one can buy KPIT Tech, Divis Lab, Punjab National Bank and Bank of Baroda.
Apr 21, 2016 at 09:33 | Source: CNBC-TV18
Prakash Gaba of prakashgaba.com is of the view that Allahabad Bank may test Rs 65 while Divis Lab may hit Rs 1083.
Apr 13, 2016 at 11:38 | Source: CNBC-TV18
An investor should give a bigger allocation to largecap funds in his portfolio because they hold lower risks. Even a first-time investor can dabble in them because they have lower risks than other funds, says Kaustubh Belapurkar of Morningstar.
Apr 07, 2016 at 15:27 | Source: CNBC-TV18
Ashwani Gujral of ashwanigujral.com recommends buying UltraTech Cement and Divis Lab and advises selling Eicher Motors.
Apr 07, 2016 at 10:55 | Source: CNBC-TV18
Sudarshan Sukhani of s2analytics.com is of the view that one can buy Maruti Suzuki at around Rs 3500.
Apr 06, 2016 at 11:46 | Source: CNBC-TV18
Ashwani Gujral of ashwanigujral.com recommends buying Tata Motors and Balrampur Chini and advises selling Divis Laboratories.
Messages on Divis Laboratories »

mktmkr

New Member

2 Followers

Divis Labs  

ONLY CHANCES ARE THAT DIVIS LABORATORIES WILL RECEIVED IS A WARNING LETTER. BUT THESE CHANCES ARE ALSO NULL. IT IS QUITE POSSIBLE THAT DIVIS LAB WILL RECEIVE A RESPONSE LETTER THAT STATES THAT OBSERVATIONS HAVE BEEN RESOLVED.

3.58 PM Feb 15th

kassetty16

New Member

0 Follower

Divis Labs  

hi Swati Medam,. I got stuck in divis laboratories at 760rs...can I hold or average at current price, please suggest.

2.34 PM Feb 7th

Wire News

Platinum Member

713 Followers

News Now  

Drug firm Divis Laboratories today reported a 8.73 per cent rise in standalone net profit to Rs 268.32 crore for the quarter ended December 31, 2016.

4.16 PM Feb 4th

Market Statistician

Platinum Member

20384 Followers

Divis Labs  

At 15:14 hrs, Divis Laboratories was trading at Rs 740.35 up 6.62%, with a huge increase in its volume of shares traded. Till now over 450,829 shares were traded as compared to its 5-day average of 208,574 shares.

3.15 PM Feb 2nd

Market Statistician

Platinum Member

20384 Followers

Divis Labs  

Divis Laboratories has touched a 52-week low of Rs 676.65. At 11:14 hrs, the share was quoting at Rs 679.85, down Rs 3.10, or 0.45%. See more

11.15 AM Jan 25th

BSE/NSE Announcer

Platinum Member

21342 Followers

Divis Labs  

Divis Laboratories Ltd has informed BSE that a meeting of Board of Directors of the Company is scheduled to be held on February 04, 2017, inter alia, to consider and approve, the un-audited financial results for the quarter and nine months ended December 31, 2016(Q3).Further, the Trading

10.14 AM Jan 23rd

Market Statistician

Platinum Member

20384 Followers

Divis Labs  

At 11:13 hrs, Divis Laboratories was trading at Rs 739.95 up 0.18%, with a huge increase in its volume of shares traded. Till now over 652,979 shares were traded as compared to its 5-day average of 270,121 shares.

11.15 AM Jan 17th

newtrader20
17

New Member

0 Follower

Divis Labs  

Divis Laboratories had set up its second manufacturing facility at Visakhapatnam (Unit-II) in 2002 on a 350-acre site.

4.06 PM Jan 10th

stockguru20
17

New Member

1 Followers

Divis Labs  

divis laboratories has filed a detailed response within the permitted time to the observations made by the us health regulator after inspection of the drug firm s manufacturing plant at visakhapatnam in andhra pradesh.

3.49 PM Jan 10th

BSE/NSE Announcer

Platinum Member

21342 Followers

Divis Labs  

Divis Laboratories Ltd has informed BSE regarding Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended December 31, 2016, under Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

11.20 AM Jan 10th

News across the web »
May 12, 2014 at 08:41 | Source: Economic Times
Explore Moneycontrol

Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.